science
plus
.abes.fr
|
explorer
À propos de :
Butini Stefania
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
foaf:Person
, within Data Space :
scienceplus.abes.fr
associated with source
document(s)
Type:
Person
New Facet based on Instances of this Class
Attributs
Valeurs
type
Person
name
Butini Stefania
familyName
Butini
Given name
Stefania
is
relates
of
http://hub.abes.fr/acs/periodical/jmcmar/1999/volume_42/issue_21/101021jm990151g/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_23/101021jm050257d/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2006/volume_49/issue_11/101021jm060257t/authorship/7
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_13/101021jm049402y/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_6/101021jm049510k/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2002/volume_45/issue_2/101021jm010982y/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/2008/volume_51/issue_20/101021jm800865a/authorship/1
http://hub.abes.fr/acs/periodical/bichaw/2005/volume_44/issue_28/101021bi047437u/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/2008/volume_51/issue_11/101021jm701253t/authorship/1
http://hub.abes.fr/acs/periodical/jmcmar/2004/volume_47/issue_1/101021jm0309811/authorship/2
http://hub.abes.fr/acs/periodical/joceah/2008/volume_73/issue_21/101021jo8015456/authorship/1
http://hub.abes.fr/acs/periodical/jmcmar/2003/volume_46/issue_18/101021jm0211220/authorship/2
http://hub.abes.fr/acs/periodical/jmcmar/2007/volume_50/issue_4/101021jm061429p/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2008/volume_51/issue_5/101021jm701247k/authorship/3
http://hub.abes.fr/acs/periodical/jmcmar/2008/volume_51/issue_5/101021jm7012375/authorship/5
http://hub.abes.fr/acs/periodical/jmcmar/2005/volume_48/issue_6/101021jm049629t/authorship/2
is
Author
of
Synthesis and Pharmacological Evaluation of Potent and Highly Selective D3Receptor Ligands: Inhibition of Cocaine-Seeking Behavior and the Role ofDopamine D3/D2 Receptors
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents.Biological Studies and Identification of an Intracellular Location of Their DrugTarget
Design, Synthesis, and Structure-Activity Relationship Studies of 4-Quinolinyl- and 9-Acrydinylhydrazones as Potent Antimalarial Agents
Novel Atypical Antipsychotic Agents: Rational Design, an EfficientPalladium-Catalyzed Route, andPharmacological Studies
Specific Targeting Highly Conserved Residues in the HIV-1 ReverseTranscriptase Primer Grip Region. Design, Synthesis, and BiologicalEvaluation of Novel, Potent, and Broad Spectrum NNRTIs with AntiviralActivity
Pyrrolo[1,3]benzothiazepine-Based Atypical Antipsychotic Agents. Synthesis,Structure−Activity Relationship, Molecular Modeling, and Biological Studies
An Efficient Approach to Chiral C8/C9-Piperazino-Substituted 1,4-Benzodiazepin-2-ones as Peptidomimetic Scaffolds
Development of Molecular Probes for the Identification of Extra InteractionSites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE).Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors
1H-Cyclopentapyrimidine-2,4(1H,3H)-dione-Related Ionotropic Glutamate Receptors Ligands. Structure−Activity Relationships and Identification of Potent and Selective iGluR5 Modulators
Pyrroloquinoxaline Derivatives as High-Affinity and Selective 5-HT3 ReceptorAgonists: Synthesis, Further Structure−Activity Relationships, and BiologicalStudies
Clotrimazole Scaffold as an Innovative Pharmacophore Towards Potent Antimalarial Agents: Design, Synthesis, and Biological and Structure-Activity Relationship Studies
Pyrrolo[1,3]benzothiazepine-Based Serotonin and Dopamine ReceptorAntagonists. Molecular Modeling, Further Structure−Activity RelationshipStudies, and Identification of Novel Atypical Antipsychotic Agents
Specific Targeting of Hepatitis C Virus NS3 RNA Helicase. Discovery of thePotent and Selective Competitive Nucleotide-Mimicking Inhibitor QU663
Discovery of Huperzine A−Tacrine Hybrids as Potent Inhibitors of Human CholinesterasesTargeting Their Midgorge Recognition Sites
Design and Synthesis of Potent AntimalarialAgents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors
Alternative Linked Data Documents:
ODE
Content Formats:
RDF
ODATA
Microdata
